Elevated BCL2 family proteins expression have been revealed in multiple human cancers, like gastric cancer (Park et al, 2015), ovarian cancer (Kurita et al, 2012; Xu et al, 2022), lung cancers (Haura et al, 2004), which are associated with chemoresistance, radioresistance, and poor prognosis. Here, BCL2 is linked to cancer.